Accessibility Menu
 
Telo Genomics logo

Telo Genomics

(OTC) TDSGF

Current Price$0.04
Market Cap$4.02M
Since IPO (2016)-99%
5 Year-93%
1 Year-34%
1 Month-2%

Telo Genomics Financials at a Glance

Market Cap

$4.02M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.43M

EPS (TTM)

$-0.02

P/E Ratio

-2.14

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Price

$0.04

Volume

10,000

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.03 - $0.09

TDSGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Telo Genomics

Industry

Biotechnology

Employees

8

CEO

Sabine Mai, PhD

Headquarters

Toronto, ON M5G 1L7, CA

TDSGF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-460%

Return on Capital

6%

Return on Assets

-8%

Earnings Yield

-46.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.02M

Shares Outstanding

100.43M

Volume

10.00K

Short Interest

0.00%

Avg. Volume

7.36K

Financials (TTM)

Gross Profit

$10.61K

Operating Income

$2.70M

EBITDA

$2.69M

Operating Cash Flow

$2.33M

Capital Expenditure

$3.25K

Free Cash Flow

$2.33M

Cash & ST Invst.

$789.29K

Total Debt

$0.00

Telo Genomics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$19.91K

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.02M

N/A

Market Cap/Employee

$502.15K

N/A

Employees

8

N/A

Net Income

$526.19K

+14.3%

EBITDA

$505.35K

+17.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$111.10K

-104.9%

Accounts Receivable

$14.97K

-49.3%

Inventory

$0.00

N/A

Long Term Debt

$83.39K

N/A

Short Term Debt

$77.79K

N/A

Return on Assets

-7.76%

N/A

Return on Invested Capital

5.54%

N/A

Free Cash Flow

$436.04K

-7.5%

Operating Cash Flow

$213.31K

+47.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RNVARennova Health, Inc.
$0.00+0.00%
TGIFF1933 Industries Inc.
$0.01+12.83%
ENZNEnzon Pharmaceuticals, Inc.
$6.00+8.11%
ICBUiMD Companies, Inc.
$0.00-20.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About TDSGF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.